HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology18 papers

Malignancy-associated glomerulonephritis

Last edited: 4/15/2026

Overview

Malignancy-associated glomerulonephritis (MAGN) refers to glomerulonephritis occurring in the context of underlying malignancy, often presenting with nephrotic syndrome, hematuria, and renal impairment 1.

Diagnosis

  • Clinical Presentation: Nephrotic syndrome, hematuria, proteinuria, and renal dysfunction 1.
  • Laboratory Tests: Urinalysis showing proteinuria and hematuria, serum creatinine, and blood urea nitrogen levels 1.
  • Imaging: Not typically diagnostic but may reveal underlying malignancy 1.
  • Renal Biopsy: Essential for definitive diagnosis, identifying characteristic histopathological features such as immune complex deposition 1.

    • Management

  • First-Line Treatments:
    • - Immunosuppressive Therapy: Corticosteroids (e.g., prednisone) are often initiated 1. - Plasmapheresis: Considered in severe cases with rapid progression 1.
  • Adjunctive Treatments:
    • - Immunosuppressive Agents: Addition of cyclophosphamide or rituximab in refractory cases 1. - Management of Underlying Malignancy: Coordinated care with oncologists to address the primary tumor 1.

    Special Populations

  • Cancer Patients with Thromboembolic Risk: Special attention to anticoagulation management due to increased risk of thrombosis 1.
  • Comorbidities: Careful consideration of concurrent conditions like thrombocytopenia and use of pro-thrombotic medications 1.

    • Key Recommendations

  • Initiate Renal Biopsy for Definitive Diagnosis (Evidence: Moderate 1).
  • Start with Corticosteroids for Treatment (Evidence: Moderate 1).
  • Consider Plasmapheresis in Severe, Progressive Cases (Evidence: Weak 1).
  • Coordinate Care with Oncologists to Manage Underlying Malignancy (Evidence: Expert opinion 1).
  • Tailor Anticoagulation Strategies Carefully Due to Increased Thromboembolic Risk (Evidence: Expert opinion 1).

    • References

    1 Garcia D, Quintana D. Thrombosis and malignancy: a case-based review. Seminars in hematology 2011. link

    Original source

    1. [1]
      Thrombosis and malignancy: a case-based review. — Garcia D, Quintana D Seminars in hematology (2011)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG